Table 3.
| donor | acceptor | E(2) | E(j) – E(i) | F(i, j) |
|---|---|---|---|---|
| (a) NBO Analysis in the Gas Phase | ||||
| nPO17 | π*C10–O11 | 1512.64 | 0.16 | 0.461 |
| nPO17 | σ*C3–C4 | 247.73 | 0.84 | 0.419 |
| nPO15 | n*C13 | 139.03 | 0.16 | 0.151 |
| nPO14 | n*C13 | 145.38 | 0.16 | 0.154 |
| n*C13 | nC6 | 653.01 | 0.02 | 0.117 |
| σC5–H9 | π*C10–O11 | 316.26 | 0.03 | 0.097 |
| σC1–H7 | π*C10–O11 | 185.00 | 0.04 | 0.079 |
| πC1–C2 | n*C3 | 57.02 | 0.15 | 0.094 |
| n*C3 | π*C4–C5 | 78.29 | 0.12 | 0.114 |
| n*C3 | π*C1–C2 | 64.96 | 0.13 | 0.108 |
| (b) NBO Analysis in the Solvent Phase | ||||
| πC16–O17 | π*C2–C3 | 106.38 | 0.02 | 0.069 |
| nPO17 | σ*C10–O11 | 208.49 | 0.73 | 0.358 |
| nPO15 | n*C13 | 150.46 | 0.15 | 0.152 |
| nPO14 | n*C13 | 155.15 | 0.15 | 0.154 |
| nPO12 | n*C10 | 147.76 | 0.16 | 0.154 |
| nPO11 | n*C10 | 183.35 | 0.15 | 0.161 |
| πC1–C6 | n*C13 | 53.21 | 0.13 | 0.082 |
| πC4–C5 | n*C10 | 40.25 | 0.14 | 0.074 |
| n*C13 | π*C1–C6 | 31.77 | 0.15 | 0.083 |
| nPO17 | σ*C2–C16 | 73.25 | 0.71 | 0.206 |
| nPO17 | σ*C5–C6 | 36.91 | 1.05 | 0.181 |